PROJECT

Projects

Summary of Investment Information

Project Number

49827

Company Name

PT Medela Potentia

Date SPI Disclosed

Apr 25, 2025

Country

Indonesia

Region

East Asia and the Pacific

Projected Board Date

Mar 14, 2025

Environmental Category

B - Limited

Status

Active

Last Updated Date

Apr 25, 2025

Department

Regional Industry - MAS Asia & Pac

Industry

other

Previous Events

Approved : Feb 20, 2025
Signed : Mar 18, 2025
Invested : Mar 25, 2025

Sector

other

Project Description

 PT Medela Potentia (Medela or the Company), is one of Indonesia's largest healthcare and pharmaceutical distribution companies. Medela was established in the 1980s as the distribution arm of PT Dexa Medica (Dexa), a leading pharmaceutical manufacturer in Indonesia. Medela and Dexa (collectively referred to as the Group) are currently owned by the Soetikno family (the Sponsor).

 

The proposal is for IFC to be a lead investor in the IPO and to invest own account equity in Indonesian Rupiah (“IDR”) of up to a maximum of (i) IDR520 billion (approximately US$35 million equivalent); or (ii) 30% of the total IPO size (the “Project”).

 

The Company plans to use proceeds from the IPO to expand its operations in Indonesia and to pursue a regional expansion strategy. As a lead investor, IFC will support the Company's IPO and help it to develop its E&S and governance standards.

 

Associated Advisory Engagement

 Additional advisory services are being explored to support Medela’s corporate governance and gender improvement program.

Sponsor / Cost / Location

Development Impact

E&S Category Rationale / Risks and Mitigation